Prenatal Screening and Diagnostic Testing
ClariTest™ Core Non-Invasive Prenatal Screening
ClariTestTM Core is a non-invasive prenatal screen (NIPS) that identifies the risk for fetal chromosomal abnormalities. ClariTest Core, a safe and simple blood draw performed as early as 10 weeks gestation, screens for the most common trisomies, sex chromosome abnormalities, and 22q11.2 microdeletions. Learn more about ClariTest Core.
Maternal Serum Screening
GenPath offerings include a number of blood tests that can provide a risk assessment for Down syndrome, trisomy 18, and open neural tube defects (ONTDs) that affect a pregnancy. Learn more about maternal serum screening.
Prenatal Diagnostic Testing
GenPath offers many different prenatal diagnostic tests performed on chorionic villus sampling (CVS) and amniocentesis samples. Learn more about prenatal diagnostic testing.